The N=91 APOE-ε4 carriers (38M/53F, age: 48.0 ± 12.5) exhibited significantly higher RVI-AD compared to non-carriers (Cohen’s d = 0.29, p = 0.03) (Fig. 1A). Here, APOE is linked to Alzheimer disease.